Author:
Francisci D.,Falcinelli F.,Schiaroli E.,Capponi M.,Belfiori B.,Flenghi L.,Baldelli F.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference29 articles.
1. Liang R, Lau GK, Kwong YL: Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. J Clin Oncol 1999; 17: 394–398.
2. Xunrong L, Yan AW, Liang R, Lau GK: Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy — pathogenesis and management. Rev Med Virol 2001; 11: 287–299.
3. Galbraight RM, Eddleston AL, Williams R, et al. Fulminating hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet 1975; 2: 528–530.
4. Takai S, Tsurumi H, Ando K, et al. Prevalence of hepatitis B and C virus infections in haematological malignancies and liver injury ollowing chemotherapy. European J Haematol 2005; 74: 156–163.
5. Hoofnagle JH, Dusheiko Gm, Schafer DF, R, Gerber MA, Klian F, et al.: Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96: 446–449.